Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001489956-22-000001
Filing Date
2022-07-18
Accepted
2022-07-15 18:03:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G_SBTX_20220715.htm SC 13G 104794
  Complete submission text file 0001489956-22-000001.txt   106301
Mailing Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2
Business Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2 416-365-2155
K2 PRINCIPAL FUND, L.P. (Filed by) CIK: 0001461790 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Subject) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91894 | Film No.: 221087778
SIC: 2834 Pharmaceutical Preparations